Representation of Intec Pharma in a public offering
Representation of Intec Pharma (NASDAQ and TASE: NTEC), in a $57.5 million public offering. For more information, click here.
Representation of Intec Pharma (NASDAQ and TASE: NTEC), in a $57.5 million public offering. For more information, click here.
Representation of R2Net, an Israeli e-commerce and diamond technology company, in its acquisition by the world’s largest jewelry retailer, Signet Jewelers (NYSE:SIG). For more information, click here.
Our firm represented Oryx Vision, an autonomous car depth sensor developer, in a $50 million funding round. For more information, click here.
Our firm represented EMK Capital in the acquisition of Luminati, the enterprise proxy network division of Hola Networks. For more information, click here.
Representation of Fireglass, an Israeli cyber company, in an agreement to be acquired by Symantec (NASDAQ:SYMC), the world’s leading cybersecurity company. For more information, click here.
Representation of Applitools, a leader in AI-powered automated visual testing and monitoring for mobile, web, and native apps, in an $8 million financing round. For more information, click here.
Our firm represented GamidaCell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, in a $40 million private financing. For more information, click here.